September 11, 2018

Rough Day For the Biotechs

Today was rough for biotechs and healthcare stocks. The market was very erratic, with very inconsistent price movement throughout the session. Our open long signals were sharply lower despite the overall bullish trend in the equities markets. A good example of this is CMDO, which rallied sharply off of earnings news, only to decline just as sharply after the open. Here’s what happened.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.

Read Similar Articles

April 6, 2026

Q1 Earnings Season Preview: What To Expect

As we start a brand new quarter in 2026, it also resets the earnings cycle for companies to report their quarterly results — and I believe that Q1 Earnings Season could have a lot in store. Q4 earnings season at the start of the year gave traders a lot to process. It also set the […]

Read Article
April 3, 2026

March 2026 Jobs Report: The Good, Bad, & Unexpected

The March 2026 Jobs Report was among the most anticipated ones in recent memory. Right now, the economy is being shaped by a number of factors: These current circumstances — combined with February’s bad jobs report — had traders preparing for the worst. Fortunately, the March 2026 Jobs Report looked much better than expected…at least […]

Read Article
January 21, 2026

Could Penny Stocks Be The Big Play In 2026?

Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]

Read Article

Read Similar Articles

June 21, 2026

The Week Ahead: We Got Warshed

Equities finished the holiday-shortened week with a more complicated message than the headline indexes suggested. The Dow Jones Industrial Average pushed to new records this week, helped by industrials and financials, while the broader market wrestled with a hawkish Federal Reserve, rising 2-year yields, and an increasingly narrow technology trade. The week’s major geopolitical headline was […]

Read Article
June 14, 2026

The Week Ahead: The Letter K

Major indices changed course in a meaningful way this past week, ending in the green despite significant initial volatility. For the week, the S&P 500, Dow and Nasdaq-100 all gained just under 1%. Headline whiplash about developments in the war between the U.S. and Iran ended with hope that an agreement is in the offing. […]

Read Article
June 13, 2026

The SpaceX IPO just made history. What comes next?

SpaceX (SPCX) closed its first day of trading up 19 percent. The biggest IPO in market history is now public, and traders are already asking the same question: What’s next for SPCX? The hype was real, but Charlie Moon believes the more interesting story is just starting to unfold. He recorded a breakdown, with his […]

Read Article